Welcome to our dedicated page for Ndt Pharmaceuticals news (Ticker: NDTP), a resource for investors and traders seeking the latest updates and insights on Ndt Pharmaceuticals stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ndt Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ndt Pharmaceuticals's position in the market.
NDT Pharmaceuticals (OTCID:NDTP) announced its subsidiary Good Salt™ Life's strategic expansion into the $148 billion global biosafety market with an innovative antimicrobial platform. The company's technology transforms salt and water into hypochlorous acid (HOCl) solutions through proprietary electrolysis, targeting home care, pet wellness, skincare, and professional biosafety sectors.
Good Salt Life has secured partnerships with major industry leaders including Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, and major retailers like Amazon, Walmart, and Chewy. The company's EPA-registered solutions are being implemented across various sectors including animal health, cruise industry, healthcare, government facilities, and sports venues.
The company is also investing in next-generation technologies including robotics, AI automation, and indoor air quality sensors to build a comprehensive safety solutions ecosystem.
NDT Pharmaceuticals (OTC:NDTP) has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based biosafety and infection control innovator, on September 5, 2025. Good Salt Life specializes in infection control ecosystems with proprietary hardware and EPA-approved chemistries, operating across 11 countries and 8 industries.
The acquired company serves major clients including Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL. Good Salt Life's portfolio encompasses consumer pet care, home care, cosmetics, antimicrobial chemistry, and chemical delivery technology. The integration aims to create cleaner, safer, and healthier solutions while focusing on sustainability and innovation.
FAQ
What is the current stock price of Ndt Pharmaceuticals (NDTP)?
What is the market cap of Ndt Pharmaceuticals (NDTP)?
